user

Risk assessment in pulmonary arterial hypertension

被引：27
|
作者：
Boucly, Athenais [1 ,2 ,3 ]
Weatherald, Jason [4 ]
Humbert, Marc [1 ,2 ,3 ]
Sitbon, Olivier [1 ,2 ,3 ]
机构：
[1] Univ Paris Saclay, Univ Paris Sud, Fac Med, Le Kremlin Bicetre, France
[2] Hop Bicetre, AP HP, Serv Pneumol, Le Kremlin Bicetre, France
[3] Hop Marie Lannelongue, INSERM UMR S 999, Le Plessis Robinson, France
[4] Univ Calgary, Div Respirol, Dept Med, Calgary, AB, Canada
来源：
EUROPEAN RESPIRATORY JOURNAL | 2018年 / 51卷 / 03期
关键词：
D O I：
10.1183/13993003.00279-2018
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Methamphetamine and the risk of pulmonary arterial hypertension
    Ramirez, Ramon L., III
    Perez, Vinicio De Jesus
    Zamanian, Roham T.
    [J]. CURRENT OPINION IN PULMONARY MEDICINE, 2018, 24 (05) : 416 - 424
  • [32] Risk Stratification in Pulmonary arterial Hypertension
    Meinrenken, Susanne
    [J]. PNEUMOLOGIE, 2022, 76 (03): : 156 - 157
  • [33] Risk stratification in pulmonary arterial hypertension
    Weatherald, Jason
    Boucly, Athenais
    Sitbon, Olivier
    [J]. CURRENT OPINION IN PULMONARY MEDICINE, 2018, 24 (05) : 407 - 415
  • [34] Risk assessment and prognosis in patients with pulmonary arterial hypertension receiving intravenous treprostinil
    Olsson, Karen
    Richter, Manuel
    Kamp, Jan C.
    Gall, Henning
    Heine, Alexander
    Ghofrani, Hossein-Ardeshir
    Fuge, Jan
    Ewert, Ralf
    Hoeper, Marius M.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [35] Risk assessment in pulmonary arterial hypertension (PAH): Insights from the GRIPHON study
    Sitbon, Olivier
    Chin, Kelly M.
    Channick, Richard N.
    Di Scala, Lilla
    Gaine, Sean
    Ghofrani, Hossein-Ardeschir
    Lang, Irene M.
    Mclaughlin, Vallerie V.
    Preiss, Ralph
    Rubin, Lewis J.
    Simonneau, Gerald
    Tapson, Victor
    Galie, Nazzareno
    Hoeper, Marius M.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [36] Regular Risk Assessment in Pulmonary Arterial Hypertension - A Whistleblower for Hidden Disease Progression
    Wu, Shu-Hao
    Wu, Yih-Jer
    [J]. ACTA CARDIOLOGICA SINICA, 2022, 38 (02) : 113 - 123
  • [37] Haemodynamics and serial risk assessment in systemic sclerosis associated pulmonary arterial hypertension
    Weatherald, Jason
    Boucly, Athenais
    Launay, David
    Cottin, Vincent
    Prevot, Gregoire
    Bourlier, Delphine
    Dauphin, Claire
    Chaouat, Ari
    Savale, Laurent
    Jais, Xavier
    Jevnikar, Mitja
    Traclet, Julie
    De Groote, Pascal
    Simonneau, Gerald
    Hachulla, Eric
    Mouthon, Luc
    Montani, David
    Humbert, Marc
    Sitbon, Olivier
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2018, 52 (04)
  • [38] Impact of body mass index on the risk assessment of mortality in pulmonary arterial hypertension
    Soliman, Youssef M. A.
    Elkorashy, Reem I. M.
    Ismail, Mohamed S.
    [J]. EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS, 2020, 69 (01): : 242 - 247
  • [39] Pulmonary Arterial Hypertension risk assessment model using Bayesian Network analysis
    Fauvel, C.
    Liu, Z.
    Lin, S.
    Correa-Jaque, P.
    Webb, A.
    Vanderpool, R.
    Benza, R.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [40] Interest of TAPSE/sPAP ratio for noninvasive pulmonary arterial hypertension risk assessment
    Fauvel, Charles
    Raitiere, Olivier
    Boucly, Athenais
    De Groote, Pascal
    Renard, Sebastien
    Bertona, Jeanne
    Lamblin, Nicolas
    Artaud-Macari, Elise
    Viacroze, Catherine
    Schleifer, Dominique
    Dominique, Stephane
    Pichon, Jeremie
    Jais, Xavier
    Montani, David
    Sitbon, Olivier
    Savale, Laurent
    Humbert, Marc
    Bauer, Fabrice
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (12): : 1761 - 1772
12345